Peptide-modified chondroitin sulfate reduces coefficient of friction at articular cartilage surface

• Published in: Current research in biotechnology 2020-11, Vol.2, p.16-21
• Main Authors: Twitchell, Celina, Walimbe, Tanaya, Liu, Julie C., Panitch, Alyssa
• Format: Article
• Language: English
• Subjects: Cartilage; Friction; Hyaluronic acid; Lubrication; Lubricin; Osteoarthritis
• ISSN: 2590-2628; 2590-2628
• DOI: 10.1016/j.crbiot.2020.02.002

Osteoarthritis is a debilitating disease that results in pain and joint stiffness. Currently, steroidal and nonsteroidal anti-inflammatory drugs and supplements aimed at restoring lubrication to the affected joint are the most successful with respect to improving patient comfort. Due to the success in lubricating therapies, there exists a keen interest to develop better therapies that mimic how lubrication occurs naturally in the joint. Here we describe the results obtained using a chondroitin sulfate chain to which is conjugated peptides that bind to either hyaluronic acid (found in high concentrations in the synovial fluid) or collagen type II (present on the cartilage surface). Our study investigates the effect of binding to the cartilage surface and interacting with hyaluronic acid on lubrication at the cartilage surface. The results described here suggest that binding to the cartilage surface is critical to supporting lubrication and did not require the addition of hyaluronic acid to reduce friction. [Display omitted] •Glycosaminoglycan binding to the cartilage surface is critical to reducing friction.•Hyaluronic acid may not be required to reduce friction at the cartilage surface.•Peptide-glycosaminoglycan conjugates can reduce cartilage friction.